Discontinuation report HEPSERA
| Report ID | 171243 |
| Drug Identification Number | 02247823 |
| Brand name | HEPSERA |
| Common or Proper name | adefovir dipivoxil |
| Company Name | GILEAD SCIENCES CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ADEFOVIR DIPIVOXIL |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30 tablets per bottle |
| ATC code | J05AF |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2022-12-21 |
| Actual discontinuation date | 2022-12-21 |
| Remaining supply date | 2023-03-15 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | Global Discontinuation |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6925 CENTURY AVENUE MISSISSAUGA, ONTARIO CANADA L5N 7K2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2022-12-27 | French | Compare |
| v5 | 2022-12-27 | English | Compare |
| v4 | 2022-11-14 | French | Compare |
| v3 | 2022-11-14 | English | Compare |
| v2 | 2022-10-06 | French | Compare |
| v1 | 2022-10-06 | English | Compare |
Showing 1 to 6 of 6